StockData
Alumis Inc. logo

Alumis Inc. (ALMS) stock

ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$4.39−0.45 (-9.19%)

Close on Nov 18, 2026Market cap $568.87MP/E –Yield –

Alumis revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Alumis's revenue for the twelve months ending Jun 30, 2026 was $7.40M. For fiscal 2025 it was $24.05M.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.05M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.66M-37.7%
Q1 FY2026Mar 31, 2026$1.74M-90.0%
Q4 FY2025Dec 31, 2025$1.93M–
Q3 FY2025Sep 30, 2025$2.07M–
Q2 FY2025Jun 30, 2025$2.67M–
Q1 FY2025Mar 31, 2025$17.39M–

More Alumis figures

See a number that looks wrong?